Abstract

Neuregulins are a family of growth and differentiation factors that act through activation of cell-surface erbB receptor tyrosine kinases and have essential functions both during development and on the growth of cancer cells. One alternatively spliced neuregulin-1 form has a distinct heparin-binding immunoglobulin-like domain that enables it to adhere to heparan sulfate proteoglycans at key locations during development and substantially potentiates its activity. We examined the structural specificity needed for neuregulin-1-heparin interactions using a gel mobility shift assay together with an assay that measures the ability of specific oligosaccharides to block erbB receptor phosphorylation in L6 muscle cells. Whereas the N-sulfate group of heparin was most important, the 2-O-sulfate and 6-O-sulfate groups also contributed to neuregulin-1 binding in these two assays. Optimal binding to neuregulin-1 required eight or more heparin disaccharides; however, as few as two disaccharides were still able to bind neuregulin-1 to a lesser extent. The physiological importance of this specificity was shown both by chemical and siRNA treatment of cultured muscle cells. Pretreatment of muscle cells with chlorate that blocks all sulfation or with an siRNA that selectively blocks N-sulfation significantly reduced erbB receptor activation by neuregulin-1 but had no effect on the activity of neuregulin-1 that lacks the heparin-binding domain. These results suggest that the regulation of glycosaminoglycan sulfation is an important biological mechanism that can modulate both the localization and potentiation of neuregulin-1 signaling.

Highlights

  • Neuregulins are a family of growth and differentiation factors that act through activation of cell-surface erbB receptor tyrosine kinases and have essential functions both during development and on the growth of cancer cells

  • We examined the structural specificity needed for neuregulin-1-heparin interactions using a gel mobility shift assay together with an assay that measures the ability of specific oligosaccharides to block erbB receptor phosphorylation in L6 muscle cells

  • Soluble isoforms of NRG1 are composed of an epidermal growth factor (EGF)-like domain, which is sufficient for receptor binding and activation of homodimers and heterodimers of erbB2, erbB3, and erbB4, and an immunoglobulin-like domain, NH2-terminal to the EGF-like domain, that is responsible for binding heparin [13,14,15]

Read more

Summary

Introduction

Neuregulins are a family of growth and differentiation factors that act through activation of cell-surface erbB receptor tyrosine kinases and have essential functions both during development and on the growth of cancer cells. 1 The abbreviations used are: HSPG, heparan sulfate proteoglycan; FGF, fibroblast growth factor; NRG, neuregulin; EGF, epidermal growth factor; Ig, immunoglobulin; IgEGF, form of NRG with both Ig and EGF-like domains; GAG, glycosaminoglycan; p185, tyrosine-phosphorylated erbB receptors; GMSA, gel mobility shift assay; NDST, N-deacetylase/N-sulfotransferase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; siRNA, small interference RNA.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call